Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$60.03 - $76.49 $216,468 - $275,822
-3,606 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$54.64 - $61.3 $60,322 - $67,675
-1,104 Reduced 23.44%
3,606 $202,000
Q2 2021

Aug 09, 2021

SELL
$59.18 - $69.99 $591 - $699
-10 Reduced 0.21%
4,710 $286,000
Q1 2021

May 14, 2021

SELL
$59.31 - $78.82 $2,135 - $2,837
-36 Reduced 0.76%
4,720 $331,000
Q4 2020

Feb 11, 2021

BUY
$50.47 - $66.26 $20,642 - $27,100
409 Added 9.41%
4,756 $285,000
Q3 2020

Nov 12, 2020

BUY
$51.97 - $63.0 $225,913 - $273,861
4,347 New
4,347 $262,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $769M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.